跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
PRIVA-CLOPIDOGREL - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
PRIVA-CLOPIDOGREL
Authorized
STANDARD
PRIVA-CLOPIDOGREL
pharmapar inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
0bfff2865dc6c055
Company
pharmapar inc
Type
Standard
Approval Details
Approval Id
0bfff2865dc6c055
Drug Approval Canada Name
PRIVA-CLOPIDOGREL
Product Name
PRIVA-CLOPIDOGREL
Status
Cancelled Post Market
Status Date
2022-07-29
Original Market Date
2020-12-11
Din
02445336
Drug Class
Human
Dosage Form
Tablet
Route Of Administration
Oral
Schedule
Prescription
Ahfs
20:12.18
Atc Original
B01AC04 CLOPIDOGREL
Atc Name
b 01 ac 04
Aig Number
0134440001
Company Name
pharmapar inc
Company Address
1565 Boul Lionel-Boulet, Varennes, Quebec, Canada, J3X 1P7
Active Ingredients
CLOPIDOGREL (CLOPIDOGREL BISULFATE)
75 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
0bfff2865dc6c055
Type
Standard
Back to Health Canada Approvals